Clearstead Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387 | Sell |
25
-94
| -79% | -$1.46K | ﹤0.01% | 2510 |
|
|
2025
Q1 | $1.77K | Sell |
119
-214
| -64% | -$3.18K | ﹤0.01% | 1916 |
|
|
2024
Q4 | $4.41K | Buy |
333
+37
| +13% | +$490 | ﹤0.01% | 1737 |
|
|
2024
Q3 | $4.21K | Sell |
296
-290
| -49% | -$4.12K | ﹤0.01% | 1736 |
|
|
2024
Q2 | $7.58K | Hold |
586
| – | – | ﹤0.01% | 1600 |
|
|
2024
Q1 | $7.68K | Buy |
586
+561
| +2,244% | +$7.35K | ﹤0.01% | 1103 |
|
|
2023
Q4 | $357 | Sell |
25
-25
| -50% | -$357 | ﹤0.01% | 1472 |
|
|
2023
Q3 | $774 | Buy |
50
+25
| +100% | +$387 | ﹤0.01% | 1469 |
|
|
2023
Q2 | $393 | Hold |
25
| – | – | ﹤0.01% | 1317 |
|
|
2023
Q1 | $412 | Hold |
25
| – | – | ﹤0.01% | 1315 |
|
|
2022
Q4 | $390 | Hold |
25
| – | – | ﹤0.01% | 1242 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 1353 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 1441 |
|
|
2022
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 1454 |
|
|
2021
Q4 | $0 | Sell |
25
-20
| -44% | – | ﹤0.01% | 1427 |
|
|
2021
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 1238 |
|
|
2021
Q2 | $1K | Hold |
45
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q1 | $1K | Hold |
45
| – | – | ﹤0.01% | 1071 |
|
|
2020
Q4 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 955 |
|